Testing effectiveness (Phase 2)Active Not RecruitingNCT04938609
What this trial is testing
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Providence Health & Services 28